Strides Arcolab has approved merger with Shasun Pharmaceuticals. The
combination creates a vertically integrated pharma company of scale with
strong presence in Front-ended Regulated Markets Finished Dosages,
Emerging Markets Branded Generics, Institutional Business, Active
Pharmaceutical Ingredients and Contract Research and Manufacturing
Services. Shashun shareholders will receive five equity shares of
Strides for every sixteen equity shares held by them in Shasun. Real Time News & Trading Trends Keep Liking Epic Research Private Limited
Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+
For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co
No comments:
Post a Comment